251 related articles for article (PubMed ID: 31170562)
1. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
[TBL] [Abstract][Full Text] [Related]
2. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
3. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
5. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
6. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
8. In-silico analysis and QSAR studies of tacrine hybrids with ubiquitin ligase on Alzheimer's disease.
Pandian RS; Hemavathi K; Jayapradha R; Seenivasagam R
Int J Bioinform Res Appl; 2010; 6(6):556-70. PubMed ID: 21354962
[TBL] [Abstract][Full Text] [Related]
9. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
Mao F; Chen J; Zhou Q; Luo Z; Huang L; Li X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6737-42. PubMed ID: 24220172
[TBL] [Abstract][Full Text] [Related]
10. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
11. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
12. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.
Ansari F; Ghasemi JB; Niazi A
Med Chem; 2020; 16(2):155-168. PubMed ID: 31092184
[TBL] [Abstract][Full Text] [Related]
13. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
[TBL] [Abstract][Full Text] [Related]
15. Design Synthesis and
Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
17. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
[TBL] [Abstract][Full Text] [Related]
18. Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study.
Attarroshan M; Firuzi O; Iraji A; Sharifi S; Tavakkoli M; Vesal M; Khoshneviszadeh M; Pirhadi S; Edraki N
Chem Biodivers; 2022 Jan; 19(1):e202100599. PubMed ID: 34786830
[TBL] [Abstract][Full Text] [Related]
19. New tacrine-derived AChE/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates.
Eghtedari M; Sarrafi Y; Nadri H; Mahdavi M; Moradi A; Homayouni Moghadam F; Emami S; Firoozpour L; Asadipour A; Sabzevari O; Foroumadi A
Eur J Med Chem; 2017 Mar; 128():237-246. PubMed ID: 28189905
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
